Global AI Radiation Dosing Market Share is Likely to Grow at a CAGR Value of 28.90% by 2028

29-Jul-2022 | Facts and Factors

According to Facts and Factors, the global AI Radiation Dosing market size was worth USD 236.40 million in 2021 and is estimated to grow to USD 1084.34 million by 2028, with a compound annual growth rate (CAGR) of approximately 28.90%over the forecast period. The report analyzes the AI Radiation Dosing market’s drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the AI Radiation Dosing market.

AI radiation dosing combines artificial intelligence with radiation dose management. The amount of radiation a patient undergoing treatment will ingest is referred to as the radiation dosage. It is expected that this will contribute to the globalization of the market for AI radiation dosing by reducing the adverse effects that these radiations have on the body parts and need monitoring and measuring these radiations. Five general areas of molecular imaging and radiation therapy, including image denoising (low-dose imaging), radiation dosimetry, computer-aided diagnostics, and PET image reconstruction quantification and segmentation, have all seen the application of artificial intelligence. Owing to the rise in demand for AI Radiation Dosing, the global AI Radiation Dosingmarket is estimated to grow at a CAGR of 28.90% during the forecast period.

Browse the full “ AI Radiation Dosing Market Size, Share, Growth Analysis Report By Type of Modalities (MRI, Ultrasound, Mammography, Computed Tomography (CT) Scan, X-ray and Others), By End User (Hospitals, Medical Institutions, Diagnostic Center and Other Medical Groups), and By Region- Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028" report at https://www.fnfresearch.com/ai-radiation-dosing-market

For patients obtaining CT scans and being exposed to X-ray radiation from the scans, radiation exposure has recently risen to the top of their list of concerns. Artificial intelligence radiation dosing has enabled low radiation dose CT scans, significantly decreasing patient anxiety. All the factors above are expected to contribute to increasing the market for AI radiation doses in the upcoming years. Additionally, reducing radiation may lead to a deterioration in image quality. In order to remove the intrusions from the CT scan images, engineers from all over the world have been concentrating and prioritizing developing effective iterative reconstruction approaches. The market for AI radiation dosing will expand as a result of the high prevalence of chronic diseases, rising elderly population, patients' growing safety concerns, and the need to enhance the standard of patient care in the developing nations of the Asia Pacific, the Middle East & Africa, and Latin America. Additionally, an increase in government spending on building strong healthcare infrastructure facilities and the requirement to reduce high radiation doses will contribute to the market's future growth.

Segmental Overview

The Global AI Radiation DosingMarket is segregated based on the type of modalities, end user, and region. Based on the variety of modalities, the market is divided into MRI, Ultrasound, Mammography, Computed Tomography (CT) Scan, X-ray and Others. Among these, the  Computed Tomography (CT) Scan segment will dominate the market in 2021. Furthermore, based on end users, the market is divided into Hospitals, Medical Institutions, Diagnostic centers and Other Medical Groups. Over the forecast period, the Hospitals segment is expected to develop at the fastest rate in 2021.

Regional Overview

North America is expected to dominate the Global AI Radiation DosingMarket in 2021because of the strict rules and certification standards for reporting and radiation dose reduction. Along with this, the region's growth will also be stimulated by the widespread adoption of HCIT procedures and the strict adherence to dose protocols in developed countries like the U.S. to increase patient safety during CT scans. On the other hand, over the forecast period, the Asia Pacific regional market is expected to grow significantly in 2021. The major factors promoting market expansion in this region include the region's expanding key market players' presence, the region's expanding healthcare infrastructure, the region's big patient population for target diseases, and the region's growing patient population for target diseases.

Report Scope

Key Players Insights

The report contains qualitative and quantitative research on the global AI Radiation Dosing Market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness. The research also identifies and analyses important business strategies used by these main market players, such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts. The study examines, among other things, each company's global presence, competitors, service offers, and standards.

Key players functioning in the global AI Radiation Dosing market include Bayer HealthCare LLC., Imalogix, Siemens Healthcare Private Limited, and others.

Recent developments:

• In June 2021, Samsung Electronics and VUNO Inc., a South Korean AI company, established strategic cooperation for integrating VUNO Med-Chest X-ray, an AI-powered mobile digital X-ray system, into the GM85. With its access to the worldwide market, this alliance is anticipated to move VUNO closer to the expansion of AI applications that are ready for the market.
• In June 2020, the CyberKnife S7 System, an advanced tool that combines speed, high precision, and real-time AI-driven motion tracking and synchronization treatment delivery for all stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments, was introduced by Accuray Incorporated (US).

The global Radiation Dosing market is segmented as follows:

By Type of Modalities

• MRI
• Ultrasound
• Mammography
• Computed Tomography (CT) Scan
• X-ray
• Others

By End User

• Hospitals
• Medical Institutions
• Diagnostic Center
• Other Medical Groups

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic Countries
    • Denmark
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com